Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data-Reference-Cited by-同舟云学术

Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data

Published:2022-01 Issue: Volume:57 Page:103433
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Epstein Samantha,Xia Zongqi,Lee Annie J.,Dahl Megan,Edwards Keith,Levit Elle,Longbrake Erin E.,Perrone Christopher,Kavak Katelyn,Weinstock-Guttman Bianca,Diallo Fatoumata,Ricci Adelle,Riley Claire S.,De Jager Philip L.,Farber Rebecca,Wesley Sarah F.

Funder

Genentech

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference27 articles.

1. Ten threats to global health in,2019

2. COVID-19 and Vaccination in the Setting of Neurologic Disease: An Emerging Issue in Neurology;Marsh;Neurology,2021

3. Perspective of patients with autoimmune diseases on COVID-19 vaccination;Boekel;Lancet Rheumatol,2021

4. Determinants of Vaccination Uptake in Risk Populations: A Comprehensive Literature Review;Doornekamp;Vaccines (Basel),2020

5. COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021;Achiron;Mult Scler,2021

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, clinical efficacy, and safety of the sinopharm (BBIBP-CorV) SARS-CoV-2 vaccine among people with multiple sclerosis receiving disease-modifying therapies: a prospective cohort study;BMC Neurology;2024-08-20

2. COVID-19 Neuroimaging Update: Pathophysiology, Acute Findings, and Post-Acute Developments;Seminars in Ultrasound, CT and MRI;2024-08

3. Aging-dependent Change in Th17 and Cytokine Response in Multiple Sclerosis;2024-03-18

4. Short-term safety of inactivated SARS-Cov-2 vaccines in Chinese patients with central nervous system inflammatory demyelinating diseases;Vaccine: X;2023-12

5. SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose;Journal of Neurology;2023-11-03